- Home
- WALD vs RNAC Comparison
WALD vs RNAC Comparison
Compare WALD & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- RNAC
- Stock Information
- Founded
- WALD 1988
- RNAC 2007
- Country
- WALD United States
- RNAC United States
- Employees
- WALD N/A
- RNAC N/A
- Industry
- WALD Package Goods/Cosmetics
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- WALD Consumer Discretionary
- RNAC Health Care
- Exchange
- WALD Nasdaq
- RNAC Nasdaq
- Market Cap
- WALD 306.3M
- RNAC 276.3M
- IPO Year
- WALD 2021
- RNAC 2016
- Fundamental
- Price
- WALD $1.56
- RNAC $10.05
- Analyst Decision
- WALD Strong Buy
- RNAC Strong Buy
- Analyst Count
- WALD 5
- RNAC 4
- Target Price
- WALD $4.96
- RNAC $40.00
- AVG Volume (30 Days)
- WALD 528.0K
- RNAC 48.4K
- Earning Date
- WALD 11-11-2025
- RNAC 08-07-2025
- Dividend Yield
- WALD N/A
- RNAC N/A
- EPS Growth
- WALD N/A
- RNAC N/A
- EPS
- WALD N/A
- RNAC N/A
- Revenue
- WALD $273,868,000.00
- RNAC $1,026,000.00
- Revenue This Year
- WALD $10.37
- RNAC N/A
- Revenue Next Year
- WALD $14.37
- RNAC N/A
- P/E Ratio
- WALD N/A
- RNAC N/A
- Revenue Growth
- WALD 25.55
- RNAC N/A
- 52 Week Low
- WALD $1.50
- RNAC $8.46
- 52 Week High
- WALD $4.40
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- WALD 35.98
- RNAC 34.71
- Support Level
- WALD $1.50
- RNAC $10.50
- Resistance Level
- WALD $1.79
- RNAC $11.80
- Average True Range (ATR)
- WALD 0.16
- RNAC 0.56
- MACD
- WALD 0.00
- RNAC -0.11
- Stochastic Oscillator
- WALD 10.00
- RNAC 0.45
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.